-
Targeted substances
- Triglyceride
- Bilirubin
- Carbamazepine
- Digoxin
- Methotrexate
- Bile acid
- Paraquat
- Myoglobin
- Cholesterol
- Inflammatory Mediators and Cytokines
- Leptin
- Ammonia
- Protein-bound toxins
- β2-MG
- Organophosphate
- PTH
- Rivaroxaban
- 2,4-dinitrophenol
- Ticagrelor
- Paracetamol
- Metformin
- ANA and ds-DNA titers
- Abrin
- Sodium valproate
- Amlodipine
- Estazolam
- Quetiapine
- Olanzapine
- Ziprasidone
- Vancomycin
- Organophosphorus
- Circulating Bacteria
- Liver Enzymes(e.g. ALT,AST)
- Vancomycin
- Gentamicin
- Poison
- Protein binded substance
- Others
-
Benefits
- Improve QOL
- Decrease Vasopressor Needs
- Stabilize Hemodynamics
- Improve oxygenation
- Bridge to Liver Transplantation
- Reduce the incidence of adverse effect
- Shorten ICU stay
- Reduce bleeding complications
- Reduce Mechanical Ventilation
- Improve Respiratory Function
- Lower the mortality rate
- Improve Liver Function
- Improve sleep efficiency
- Improve HE
- Improve renal function
- Relieve Uremic Pruritis
- Reduce Cardiovascular Related Events
- Improve Survival Rate
- Remove inflammatory markers/ cytokines
- Reduce circulating bacterial load
- Improve disease symptoms
- Improve laboratory parameters
- Others
- Disease
- Endocarditis
- Poisoning/Drug overdose
- Leptospirosis
- Sepsis/ Septic Shock
- Multiple Myeloma
- Severe Acute Pancreatitis(SAP)
- Multiple Organ Dysfunction Syndrome(MODS)
- Rhabdomyolysis
- Dengue
- Leukemia-Sepsis
- Burn
- Trauma
- Open Heart Surgery
- Acute Respiratory Distress Syndrome (ARDS)
- Hepatic Encephalopathy(HE)
- End Stage Renal Disease(ESRD)
- Acute Kidney Injury(AKI)
- Systemic Lupus Erythematosus (SLE)
- Liver Transplantation
- Liver Failure(LF)
- Jaudice
- Subarachnoid Hemorrhage
- Symmetrical Peripheral Gangrene(SPG)
- Wasp Stings
- Acute Renal Failure
- Hepatitis
- Cardiopulmonary Bypass(CPB)
- Severe Liver Injury
- Henoch-Schönlein purpura (HSP)
- COVID-19
- Polymyositis
- Liver Cirrhosis
- Hyperbilirubinemia
- Maintenance Hemodialysis (MHD)
- Crush syndrome
- Human Immunodeficiency Virus(HIV)
- Immunological diseases (IMD)
- Hyperlipidemia
- Infection
- Others
-
The impact of artificial liver support system on intestinal microbiota and serum bile acid profiles in patients with acute-on-chronic liver failure
Zeng Y, Gan D, Zhang K, et al. [J]. 2024.
-
Classification of Uremic Toxins and Their Role in Kidney Failure
Rosner M H, Reis T, Husain-Syed F, et al. [J]. Clinical Journal of the American Society of Nephrology, 2021, 16(12): 1918-1928.
-
42nd Vicenza Course Abstracts
42nd Vicenza Course on AKI-CRRT-ECOS, 11-13 June 2024, Vicenza, Italy
-
The Revival of Sorbents in Chronic Dialysis Treatment
-
Tralopyril poisoning due to respiratory exposure
-
Effectiveness of Combined Hemodialysis-Hemadsorption Therapy in Improving Uremic Toxin Clearance, Inflammatory Markers, and Symptoms in Maintenance Hemodialysis Patients
-
Care Bundles to Improve Hemoperfusion Performance in Patients with Severe COVID-19: A Retrospective Study
Mueankwan S, Trongtrakul K, Tajarernmuang P, et al. [J]. Journal of Clinical Medicine, 2024, 13(12): 3360.
-
Mortality Rate and Acute Kidney Injury Prevalence Reduction in COVID‑19 Critical Patients Treated with Hemoperfusion
Barriga-Moreno A P, Lozano-Sanchez M, Barón-Alvarez R A, et al. [J]. Indian Journal of Nephrology, 2023: 10.4103.
-
Observation on the Effect of Sequentially Combined Multi-modal Artificial Liver Treatment on HBV-related Acute-on-chronic Liver Failure
Zhou X, Miu Y, Guo X, et al. [J]. Current Molecular Medicine, 2024, 24(9): 1152-1158.
-
Outcome of patients with different stages of acute-on-chronic liver failure treated with artificial liver support system
Ma Y, Xu Y, Du L, et al. [J]. Frontiers in Medicine, 2024, 11: 1381386.
-
Haemoadsorption in Critically Ill Patients: The New Frontier
Ronco. ICU Management & Practice 1 - 2024
-
Hemoadsorption Combined with Hemodialysis and the "Inflammation Mitigation Hypothesis"
Brendolan A, Lorenzin A, De Cal M, et al. [J]. Integrative Medicine in Nephrology and Andrology, 2024, 11(1): e00006.
-
In vitro Removal of Protein-Bound Retention Solutes by Extracorporeal Blood Purification Procedures
Schildböck C, Harm S, Hartmann J. [J]. Blood Purification, 2024.
-
Early Hemoperfusion Application in Severe and Critical COVID-19 Treatment: a Randomized, Controlled Trial
Srisawat N, Surasit K. l[J]. Controlled Trial.
-
Double plasma molecular adsorption system for Stevens–Johnson syndrome/toxic epidermal necrolysis: A case report
Tan Y W, Liu L P, Zhang K. [J]. World Journal of Clinical Cases, 2024, 12(7): 1371-1377.
-
Hemoadsorption
Bellomo R, Mehta R L, Forni L G, et al. [J]. Clinical Journal of the American Society of Nephrology, 2024: 10.2215.
-
EFFECT OF MECHANICAL VIBRATION ON KINETICS OF SOLUTE ADSORPTION
Ramírez-Guerrero G, Reis T, Lorenzin A, et al. [J]. Blood Purification, 2024.
-
Adsorption Mass Transfer Zone of Vancomycin in Cartridges With Styrene-Divinylbenzene Sorbent
Reis T, Ronco C, Ramírez-Guerrero G, et al. [J]. ASAIO Journal, 2024: 10.1097.
-
Removal of inflammatory factors and prognosis of patients with septic shock complicated with acute kidney injury by hemodiafiltration combined with HA330-II hemoperfusion
Zhou J, Li H, Zhang L, et al. [J]. Therapeutic Apheresis and Dialysis, 2024.
-
Which Patient Phenotype Is the Ideal Candidate for Hemoadsorption in Acute and Chronic Kidney Disease?
Ronco C, Kellum J A. [J]. Integrative Medicine in Nephrology and Andrology, 2024, 11(1): e00001.